FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2553501037> ?p ?o ?g. }

• W2553501037 endingPage "44" @default.
• W2553501037 startingPage "36" @default.
• W2553501037 abstract "Cytokine induced killer (CIK) cells have a powerful tumor cells killing activity both in vitro and in vivo and transfusion of these cells have become an adjuvant treatment for tumors. CIK cells are induced and amplified from peripheral blood mononuclear cells (PBMCs) with multiple cytokines. As CD4+CD25bri regulatory T cells can be also induced by high dose of interleukin 2 (IL-2) which is used for CIK cells amplification in the CIK cell culture system, the anti-tumor activity of CIK cells was suppressed to some extent. In order to overcome this unwanted suppressive factor, we found that low dose of gemcitabine could reduce the proportion of CD4+CD25bri regulatory T cells in the CIK cell culture system and significantly enhance the anti-tumor activity of CIK cells in vitro. The levels of interleukin-10 (IL-10) and transforming growth factor-β (TGF-β) were also reduced significantly following the depletion of CD4+CD25bri regulatory T cells in gemcitabine treated CIK cell culture system. In vivo experiment showed that low dose of gemcitabine treated CIK cells significantly suppressed tumor growth and prolonged their lifespan in tumor-bearing nude mice, with the proportion of CD4+CD25bri regulatory T cells reduced. Meanwhile, we detected lower levels of IL-10, TGF-β and a higher level of interferon-γ (IFN-γ) in tumor-bearing nude mice that received gemcitabine treated CIK cells transfusion than those in other groups. The possible mechanism involved in the enhanced anti-tumor activity in vivo was that gemcitabine treated CIK cells created a strengthened anti-tumor immune microenvironment with the changed levels of cytokines such as IL-10, TGF-β and IFN-γ. These results suggested a strategy to improve the adoptive immune therapy in recent use by removing the suppressive factors and a more effective tumor treatment combining chemotherapy and immunotherapy." @default.
• W2553501037 created "2016-11-30" @default.
• W2553501037 creator A5005445571 @default.
• W2553501037 creator A5034304687 @default.
• W2553501037 creator A5038519600 @default.
• W2553501037 creator A5038570772 @default.
• W2553501037 creator A5047928155 @default.
• W2553501037 creator A5053982706 @default.
• W2553501037 creator A5057131883 @default.
• W2553501037 creator A5078513647 @default.
• W2553501037 creator A5079480318 @default.
• W2553501037 creator A5080280424 @default.
• W2553501037 creator A5085643062 @default.
• W2553501037 date "2017-01-01" @default.
• W2553501037 modified "2023-10-16" @default.
• W2553501037 title "Gemcitabine treatment enhanced the anti-tumor effect of cytokine induced killer cells by depletion of CD4+CD25bri regulatory T cells" @default.
• W2553501037 cites W1518759830 @default.
• W2553501037 cites W1545264161 @default.
• W2553501037 cites W1642873092 @default.
• W2553501037 cites W1971012938 @default.
• W2553501037 cites W1973091654 @default.
• W2553501037 cites W1979235929 @default.
• W2553501037 cites W1983134200 @default.
• W2553501037 cites W1983726996 @default.
• W2553501037 cites W1984519174 @default.
• W2553501037 cites W1985735048 @default.
• W2553501037 cites W1985981664 @default.
• W2553501037 cites W1992641327 @default.
• W2553501037 cites W2005438334 @default.
• W2553501037 cites W2025071298 @default.
• W2553501037 cites W2034625094 @default.
• W2553501037 cites W2042702383 @default.
• W2553501037 cites W2050315424 @default.
• W2553501037 cites W2052072562 @default.
• W2553501037 cites W2053737749 @default.
• W2553501037 cites W2058039965 @default.
• W2553501037 cites W2062461507 @default.
• W2553501037 cites W2062713220 @default.
• W2553501037 cites W2074947114 @default.
• W2553501037 cites W2079068389 @default.
• W2553501037 cites W2090806526 @default.
• W2553501037 cites W2091262320 @default.
• W2553501037 cites W2093608608 @default.
• W2553501037 cites W2099657378 @default.
• W2553501037 cites W2101189819 @default.
• W2553501037 cites W2111415894 @default.
• W2553501037 cites W2131778873 @default.
• W2553501037 cites W2133114658 @default.
• W2553501037 cites W2134638467 @default.
• W2553501037 cites W2134724142 @default.
• W2553501037 cites W2134768631 @default.
• W2553501037 cites W2138032761 @default.
• W2553501037 cites W2138163780 @default.
• W2553501037 cites W2144031118 @default.
• W2553501037 cites W2144751606 @default.
• W2553501037 cites W2147279394 @default.
• W2553501037 cites W2148226248 @default.
• W2553501037 cites W2148245227 @default.
• W2553501037 cites W2159357905 @default.
• W2553501037 cites W2163184777 @default.
• W2553501037 cites W2166438464 @default.
• W2553501037 cites W2312498157 @default.
• W2553501037 doi "https://doi.org/10.1016/j.imlet.2016.11.009" @default.
• W2553501037 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27867030" @default.
• W2553501037 hasPublicationYear "2017" @default.
• W2553501037 type Work @default.
• W2553501037 sameAs 2553501037 @default.
• W2553501037 citedByCount "3" @default.
• W2553501037 countsByYear W25535010372020 @default.
• W2553501037 countsByYear W25535010372021 @default.
• W2553501037 countsByYear W25535010372022 @default.
• W2553501037 crossrefType "journal-article" @default.
• W2553501037 hasAuthorship W2553501037A5005445571 @default.
• W2553501037 hasAuthorship W2553501037A5034304687 @default.
• W2553501037 hasAuthorship W2553501037A5038519600 @default.
• W2553501037 hasAuthorship W2553501037A5038570772 @default.
• W2553501037 hasAuthorship W2553501037A5047928155 @default.
• W2553501037 hasAuthorship W2553501037A5053982706 @default.
• W2553501037 hasAuthorship W2553501037A5057131883 @default.
• W2553501037 hasAuthorship W2553501037A5078513647 @default.
• W2553501037 hasAuthorship W2553501037A5079480318 @default.
• W2553501037 hasAuthorship W2553501037A5080280424 @default.
• W2553501037 hasAuthorship W2553501037A5085643062 @default.
• W2553501037 hasConcept C114684123 @default.
• W2553501037 hasConcept C126322002 @default.
• W2553501037 hasConcept C137061746 @default.
• W2553501037 hasConcept C150903083 @default.
• W2553501037 hasConcept C167672396 @default.
• W2553501037 hasConcept C185592680 @default.
• W2553501037 hasConcept C202751555 @default.
• W2553501037 hasConcept C203014093 @default.
• W2553501037 hasConcept C207001950 @default.
• W2553501037 hasConcept C26291073 @default.
• W2553501037 hasConcept C2776107976 @default.
• W2553501037 hasConcept C2776694085 @default.
• W2553501037 hasConcept C2778690821 @default.
• W2553501037 hasConcept C2779109515 @default.
• W2553501037 hasConcept C2780258809 @default.

• next